Literature DB >> 19807886

Parent-assisted or nurse-assisted epidural analgesia: is this feasible in pediatric patients?

Patrick K Birmingham1, Santhanam Suresh, Andrew Ambrosy, Suzanne Porfyris.   

Abstract

AIM: The aim of this study was to assess the feasibility of parent-assisted or nurse-assisted epidural analgesia (PNEA) for control of postoperative pain in a pediatric surgical population.
METHODS: After the institutional review board (IRB) approval was obtained, an analysis of our pain treatment services database of pediatric surgical patients with epidural catheters in whom the parent and/or nurse were empowered to activate the epidural demand-dose button was evaluated.
RESULTS: Over a 10 -year period between 1999 and 2008, 128 procedures in 126 patients were provided parent or nurse assistance of the epidural demand dose. Satisfactory analgesia was obtained in 86% of patients with no or minor adjustments in PNEA parameters. Fourteen percent of patients were converted to intravenous patient-controlled analgesia (PCA) for inadequate analgesia (7%) or side effects (7%). None of the patients in this cohort required treatment for respiratory depression or excessive sedation.
CONCLUSIONS: Parent-assisted or nurse-assisted epidural analgesia can be safely administered to children undergoing surgery who are physically or cognitively unable or unwilling to self-activate a demand dose. Additional studies are needed to compare the efficacy of PNEA with other modalities for postoperative pain control in children.

Entities:  

Mesh:

Year:  2009        PMID: 19807886     DOI: 10.1111/j.1460-9592.2009.03151.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  2 in total

1.  Comparison of Morphine- and Hydromorphone-Containing Patient-Controlled Epidural Analgesia Solutions in Pediatric Postoperative Patients.

Authors:  Jesse Cramer
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

2.  Acute pain management in children.

Authors:  Susan T Verghese; Raafat S Hannallah
Journal:  J Pain Res       Date:  2010-07-15       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.